The DOI matches its Crossref record; 85 of the 88 references it cites were found in a registry or an index.
International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer
Open accessAbstract
Background: Screening individuals at increased risk for pancreatic cancer (PC) detects early, potentially curable, pancreatic neoplasia. Objective: To develop consortium statements on screening, surveillance and management of high-risk individuals with an inherited predisposition to PC. Methods: A 49-expert multidisciplinary international consortium met to discuss pancreatic screening and vote on statements. Consensus was considered reached if ≥75% agreed or disagreed. Results: There was excellent agreement that, to be successful, a screening programme should detect and treat T1N0M0 margin-negative PC and high-grade dysplastic precursor lesions (pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasm). It was agreed that the following were candidates for screening: first-degree relatives (FDRs) of patients with PC from a familial PC kindred with at least two affected FDRs; patients with Peutz–Jeghers syndrome; and p16 , BRCA 2 and hereditary non-polyposis colorectal cancer (HNPCC) mutation carriers with ≥1 affected FDR. Consensus was not reached for the age to initiate screening or stop surveillance. It was agreed that initial screening should include endoscopic ultrasonography (EUS) and/or MRI/magnetic resonance cholangiopancreatography not CT or endoscopic retrograde cholangiopancreatography. There was no consensus on the need for EUS fine-needle aspiration to evaluate cysts. There was disagreement on optimal screening modalities and intervals for follow-up imaging. When surgery is recommended it should be performed at a high-volume centre. There was great disagreement as to which screening abnormalities were of sufficient concern to for surgery to be recommended. Conclusions: Screening is recommended for high-risk individuals, but more evidence is needed, particularly for how to manage patients with detected lesions. Screening and subsequent management should take place at high-volume centres with multidisciplinary teams, preferably within research protocols.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Pancreas surveillance has been recommended for individuals estimated to be at high risk of developing PDAC (5% or higher estimated lifetime risk).5-8”
From The Multicenter Cancer of Pancreas Screening Study: Impact on Stage and Survival (2022) · cites this paper as [5]
In the citing paper
“The US Preventive Services Task Force and other guidelines recommend against screening for pancreatic ductal adenocarcinoma in asymptomatic adults at average risk.6,53,54”
From Early detection of pancreatic cancer (2020) · cites this paper as [6]
In the citing paper
“All screening programmes for pancreatic ductal adenocarcinoma aim to detect and treat T1N0M0 cancers or high-grade dysplastic premalignant lesions (ie, pancreatic intraepithelial neoplasia 3 or mucinous cystic tumours with high-grade dysplasia).6,54”
From Early detection of pancreatic cancer (2020) · cites this paper as [6]
In the citing paper
“This target includes individuals with at least two first-degree relatives with pancreatic ductal adenocarcinoma, patients with hereditary pancreatitis or particular genetic syndromes (eg, Peutz-Jeghers syndrome, or germline mutations in the CDKN2A, BRCA2, or PALB2),6,54 and individuals with mucinous cystic lesions of the pancreas.19–21”
From Early detection of pancreatic cancer (2020) · cites this paper as [6]
In the citing paper
“However, international guidelines and a white paper on the early detection of pancreatic ductal adenocarcinoma recommend targeted screening of individuals whose lifetime risk of developing pancreatic ductal adenocarcinoma is higher than 5% (figure 1).6,54”
From Early detection of pancreatic cancer (2020) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Ferlay, J., Ward, E., & Forman, D. (2011) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 55,077
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer Deaths
Zauber, A. G., Winawer, S. J., O’Brien, M. J., Lansdorp‐Vogelaar, I., van Ballegooijen, M., Hankey, B. F., Shi, W., Bond, J. H., Schapiro, M., Panish, J. F., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1100370 · Cited by 3,185
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Yachida, S., Jones, S., Bozic, I., Antal, T., Leary, R., Fu, B., Kamiyama, M., Hruban, R. H., Eshleman, J. R., Nowak, M. A., et al. (2010) · Nature · doi:10.1038/nature09515 · Cited by 2,502
Self-citationInternational consensus guidelines 2012 for the management of IPMN and MCN of the pancreas
Tanaka, M., Fernández-del Castillo, C., Adsay, V., Chari, S., Falconi, M., Jang, J.-Y., Kimura, W., Levy, P., Pitman, M. B., Schmidt, C. M., et al. (2012) · Pancreatology · doi:10.1016/j.pan.2012.04.004 · Cited by 2,354
Tanaka, M., Chari, S. T., Adsay, V. N., Carlos, F.-D., Falconi, M., Shimizu, M., Yamaguchi, K., Yamao, K., & Matsuno, S. (2005) · Pancreatology · doi:10.1159/000090023 · Cited by 2,042
An Assessment of Clinically Useful Measures of the Consequences of Treatment
Laupacis, A., Sackett, D. L., & Roberts, R. S. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806303182605 · Cited by 1,681
1423 Pancreaticoduodenectomies for Pancreatic Cancer: A Single-Institution Experience
Winter, J. M., Cameron, J. L., Campbell, K. A., Arnold, M. A., Chang, D. C., Coleman, J., Hodgin, M. B., Sauter, P. K., Hruban, R. H., Riall, T. S., et al. (2006) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2006.08.018 · Cited by 1,491
Self-citationVery high risk of cancer in familial Peutz–Jeghers syndrome
Giardiello, F. M., Brensinger, J. D., Tersmette, A. C., Goodman, S. N., Petersen, G. M., Booker, S. V., Cruz–Correa, M., & Offerhaus, G. J. A. (2000) · Gastroenterology · doi:10.1053/gast.2000.20228 · Cited by 1,435
Self-citation
Cited by
Sorted by citations
Items 701–785 of 785
Skipworth, J. R. A., & Pereira, S. P. (2020) · doi:10.1093/med/9780198746690.003.0337
Molecular and morphologic study of pancreatic cancer evolution
Noë, M. (2020) · Utrecht University Repository (Utrecht University) · doi:10.33540/3
Improving Outcomes in Pancreatic Cancer
Sharman, R., & Shroff, R. T. (2020) · touchREVIEWS in Oncology & Haematology · doi:10.17925/ohr.2020.16.1.59
Familiäre gastrointestinale Tumorerkrankungen: daran denken!
Djanani, A. M. (2020) · Journal für Gastroenterologische und Hepatologische Erkrankungen · doi:10.1007/s41971-020-00085-3
The Increasing Proportion of Early-Stage Pancreatic Cancer between 2004–2013: A SEER Analysis
Oman, S. P., Corral, J. E., Stauffer, J. A., Raimondo, M., Mody, K., & Wallace, M. B. (2021) · Cancer Investigation · doi:10.1080/07357907.2021.1888386
Chalhoub, J. M., & Andrawes, S. (2021) · Clinical gastroenterology · doi:10.1007/978-3-030-69940-6_8
Epidemiological Impact of Pancreatic Cancer
Maisonneuve, P. (2021) · doi:10.1002/9781119570097.ch49
Role of Endoscopic Ultrasound in Pancreatic Cancer Screening
Cannizzaro, R., Magris, R., Maiero, S., Guarnieri, G., Fornasarig, M., & Canzonieri, V. (2021) · Springer eBooks · doi:10.1007/978-3-030-71937-1_11
Buscail, L., Bournet, B., Carrère, N., Muscari, F., & Otal, P. (2021) · Elsevier eBooks · doi:10.1016/b978-2-294-77623-6.00006-7
Cancer du pancréas : épidémiologie, dépistage, diagnostic et bilan d'extension
Morgant, S., Munoz, L. A., Védié, A., Oumrani, S., Dermine, S., Hentic, O., Maire, F., Müller, N., Laurent, L., Cros, J. F., et al. (2021)
Etiology and early detection of pancreatic cancer
Yu, J. (2021) · Figshare
Integration into cancer studies
Viswanath, P. (2021) · Advances in magnetic resonance technology and applications · doi:10.1016/b978-0-12-822269-0.00010-5
Reducing the Risk of and Screening for Pancreatic Cancer
Kothari, S., Kaul, V., & Kothari, T. H. (2021) · Springer eBooks · doi:10.1007/978-3-030-37482-2_35-1
Diagnosis and Evaluation of Pancreatic and Periampullary Adenocarcinoma
Lew, D., & Kwok, K. K. (2021) · Springer eBooks · doi:10.1007/978-3-030-37482-2_29-1
Shane-Carson, K., & Jeter, J. (2019) · Springer eBooks · doi:10.1007/978-3-030-15935-1_6
Schwartz, I., Sharma, P., Vankawala, P., Cruz, N., Abraham, R. R., Sussman, D. A., & Girotra, M. (2022) · Pancreas · doi:10.1097/mpa.0000000000001969
Akushevich, I. V., Yashkin, A. P., Kovtun, M., Yashin, A. I., & Kravchenko, J. S. (2022) · Research Square · doi:10.21203/rs.3.rs-1274934/v1
Germline pathogenic variants in patients with pancreatic cancer
Morizane, C. (2022) · Suizo · doi:10.2958/suizo.37.22
Hamman, K. J., Kohlmann, W. K., & Leachman, S. A. (2017) · Springer eBooks · doi:10.1007/978-1-4614-7322-0_8-1
Macgregor‐Das, A. M., & Goggins, M. (2017) · Springer eBooks · doi:10.1007/978-1-4939-6631-8_56-1
Self-citationWatson, J., Hydon, K., & Adair, R. A. (2016) · InnovAiT Education and inspiration for general practice · doi:10.1177/1755738016655559
Multiparameter Modalities for the Study of Patients in the Setting of Individualized Medicine
Miyabayashi, K., Tuveson, D. A., & Yu, K. H. (2017) · Springer eBooks · doi:10.1007/978-1-4939-6631-8_65-1
Weiss, J. M., Zakas, A. L., & Hause, J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817344-2.00013-7
Hamman, K. J., Kohlmann, W. K., & Leachman, S. A. (2019) · Springer eBooks · doi:10.1007/978-1-4614-7147-9_8
EUS and Its Role in Pancreatic Cancer
Grote, T., & Gress, T. M. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7193-0_79
Research Progress in Pancreatic Cancer
王, 登. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.126751
The MD Anderson Cancer Center Moon Shots Program®: A Global Priority
Papadopoulos, P. C., Roarty, E. B., Bello, R. S., Domgue, J. F., Shete, S. S., & Maitra, A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-69584-8.00062-1
Korenevskiy, N. A., Okhotnikov, O. I., Belozerov, V. A., & Rodionova, S. N. (2022) · Biomedical Engineering · doi:10.1007/s10527-022-10183-6
Why, Who and How We Should Screen for Melanoma
Clarysse, K. L. J., & Lacy, K. E. (2022) · Current Genetic Medicine Reports · doi:10.1007/s40142-022-00204-x
Hereditary Cancer Syndromes: Risk Assessment and Genetic Counseling
Bluebond, R., Bannon, S. A., Hyde, S. M., Woodson, A., You, N., Lu, K. H., & Arun, B. (2022) · Wiley eBooks · doi:10.1002/9781119000822.hfcm143.pub2
Pankreaskarzinom – Screening oder Surveillance: Was ergibt Sinn?
Sirtl, S., Vornhülz, M., Hofmann, F. O., Mayerle, J. V., & Beyer, G. (2022) · Die Gastroenterologie · doi:10.1007/s11377-022-00652-5
Kana, M. A., Khanijahani, A., Raji, I. A., Adamu, A. A., & Linkov, F. Y. (2022) · Health informatics · doi:10.1007/978-3-031-07912-2_12 · Cited by 1
Reducing the Risk of and Screening for Pancreatic Cancer
Kothari, S., Kaul, V., & Kothari, T. H. (2022) · Springer eBooks · doi:10.1007/978-3-030-41683-6_35
Mechanisms and Evidence on Pancreatic Cancer Prevention
Hasanov, M., Montiel, M. F., Bhutani, M. S., & McAllister, F. M. (2022) · Springer eBooks · doi:10.1007/978-3-031-05724-3_25
Diagnosis and Evaluation of Pancreatic and Periampullary Adenocarcinoma
Lew, D., & Kwok, K. K. (2022) · Springer eBooks · doi:10.1007/978-3-030-41683-6_29
Cribado de cáncer de páncreas en la práctica clínica: es el momento de la prevención
Merino, L. A., Mora-Soler, A., la Fuente, C. Z.-D., Gallego, F. G., Crivillén, O., & Ponferrada, Á. (2023) · Revista de Gastroenterología del Perú · doi:10.47892/rgp.2022.424.1373
Das familiäre Pankreaskarzinomsyndrom
Seifert, L., & Weitz, J. (2023) · Die Chirurgie · doi:10.1007/s00104-023-01819-8
Projects for early diagnosis of pancreatic cancer focusing on risk factors
Hanada, K. (2023) · Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening) · doi:10.3804/jjabcs.32.1
Hall, M. J., Bernhisel, R., Hughes, E., Larson, K., Rosenthal, E. T., Singh, N. A., Lancaster, J. M., & Kurian, A. W. (2023) · doi:10.1158/1940-6207.22534658
Muñoz, Á. N., Sanchez-Matamoros, I., Tuñón, J. M. C., & Luque, J. A. B. (2023) · Springer eBooks · doi:10.1007/978-3-031-21351-9_5
Brügel, M., Marulier, T., Evrard, C., Carlier, C., Tougeron, D., Piessen, G., Truant, S., Turpin, A., Williet, N., Botsen, D., et al. (2023) · Pancreatology · doi:10.1016/j.pan.2023.06.010
Screening of Hereditary Pancreatic Cancer
Goggins, M. (2023) · Wiley eBooks · doi:10.1002/9781119876007.ch130
Self-citationPancreatic and Biliary Tract Cancers
Ney, A., Osei‐Bordom, D., García-Sampedro, A., Acedo, P., Fusai, G., Stott, M. C., Hopley, P. J., Patel, C., Oldfield, L. S., Greenhalf, W., et al. (2024) · Wiley eBooks · doi:10.1002/9781119756422.ch17
Screening for Early Diagnosis of Pancreatic Cancer
Hanada, K., Shimizu, A., Tsushima, K., Ikeda, M., & Tazuma, S. (2023) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.112.250
Pankreaskarzinom – Screening oder Surveillance: Was ergibt Sinn?
Sirtl, S., Vornhülz, M., Hofmann, F. O., Mayerle, J. V., & Beyer, G. (2024) · best practice onkologie · doi:10.1007/s11654-024-00556-6
Yoshimura, D., Fukasawa, M., Yoda, Y., Ohtaka, M., Ooka, T., Takano, S., Kawakami, S., Fukasawa, Y., Kuratomi, N., Harai, S., et al. (2024) · Diagnostics · doi:10.3390/diagnostics14060651
Uchida, N., Takehita, M., & Suda, T. (2024) · International Cancer Conference Journal · doi:10.1007/s13691-024-00705-2
Hijioka, S., Morizane, C., & Okusaka, T. (2024) · Suizo · doi:10.2958/suizo.39.215
Kazemi-Harikandei, S.-Z., Karimi, A., & Tavangar, S. M. (2024) · Middle East Journal of Digestive Diseases · doi:10.34172/mejdd.2024.387
Assessment of dyspepsia in the era of endoscopic ultrasonography
Talkhan, M. G., & Elsayed, M. O. K. (2024) · Gastroenterology and Functional Medicine · doi:10.54844/gfm.2023.441
Systemic treatment for advanced hepatocellular carcinoma of non-viral causes
Cidón, E. U., & Martinez, P. A. (2024) · Gastroenterology and Functional Medicine · doi:10.54844/gfm.2024.753
Wiegand, A., Chhoda, A., Namboodiri, A., Grimshaw, A. A., Dalela, D., & Farrell, J. J. (2025) · Journal of Genetic Counseling · doi:10.1002/jgc4.2016
Possibilities for early detection of pancreatic cancer
Dosoudilová, M., Kasparova, K., Dolečková, Z., & Grodová, K. (2024) · Klinická biochemie a metabolismus · doi:10.61568/kbm.2024.013
Vitali, F., & Aghdassi, A. A. (2025) · Die Gastroenterologie · doi:10.1007/s11377-025-00920-0
Zhu, C., Peng, P., Liu, Y., Zhao, Y., Cheng, R., Liu, Y., & Yin, J. (2025) · Computer Methods in Biomechanics & Biomedical Engineering · doi:10.1080/10255842.2025.2525979
Tavano, F., Gioffreda, D., Fontana, A., Palmieri, O., Gentile, A., Latiano, T., Latiano, A., Latiano, T. P., Scaramuzzi, M., Maiello, E., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26564961
Tavano, F., Gioffreda, D., Fontana, A., Palmieri, O., Gentile, A., Latiano, T., Latiano, A., Latiano, T. P., Scaramuzzi, M., Maiello, E., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26564964
Gao, L., Ugalde, A., Livingston, P. M., White, V., Watts, J. J., Jongebloed, H., McCaffrey, N., Menzies, D., & Robinson, S. (2024) · Figshare · doi:10.6084/m9.figshare.26685012
Dayem Ullah, A. Z. M., Stasinos, K., Chelala, C., & Kocher, H. M. (2021) · Figshare · doi:10.6084/m9.figshare.17088398
Dayem Ullah, A. Z. M., Stasinos, K., Chelala, C., & Kocher, H. M. (2021) · Figshare · doi:10.6084/m9.figshare.17088392
Dayem Ullah, A. Z. M., Stasinos, K., Chelala, C., & Kocher, H. M. (2021) · Figshare · doi:10.6084/m9.figshare.17088395
Risk score development for pancreatic cancer in Chinese men: A population-based cohort study
Cai, J., Chen, H., Zhang, Y., Lü, B., Lu, M. J., Luo, C., You, L., & Dai, M. (2026) · Cancer Epidemiology · doi:10.1016/j.canep.2026.102994
Chronische Pankreatitis als Risiko für ein okkultes Pankreaskarzinom
Scherübl, H. (2026) · Journal für Gastroenterologische und Hepatologische Erkrankungen · doi:10.1007/s41971-025-00248-0
Li, S., Zhang, C., Lv, S., Zhang, Z., Xu, D., & Xu, T. (2026) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s562602
Baraian, S. C., Turculet, C. Ş., & Negoi, I. (2026) · Cancers · doi:10.3390/cancers18060976
Factors affecting compliance with pancreas surveillance in patients with familial/genetic risk
Sleiman, E. A., Sinan, H., Shin, E. J., Canto, M. I., & Goggins, M. (2026) · Familial Cancer · doi:10.1007/s10689-026-00542-7
Self-citationLorenzo, D. (2024) · theses.fr (ABES) · doi:10.70675/ba1107b2ze1c9z4e6ezad24z3a1778a18d7e
Lahtinen, E., Shigiltchoff, N., Jia, K., Kundrot, S., Palchuk, M. B., Warnick, J., Chan, L., Kaplan, I. D., Sawhney, M., Rinard, M., et al. (2026) · medRxiv · doi:10.64898/2026.04.11.26350318
Nishio, M., Sugiyama, H., McCormack, V., Viguier, J., Quesnel, B., Iovanna, J., Dusetti, N., Hammel, P. R., Henrion, M. C., Monge, C., et al. (2026) · JCO Global Oncology · doi:10.1200/go-25-00483
Rassy, E., Delaloge, S., Truong, T., Bouteille, L., Pudlarz, T., Boilève, A., Michiels, S., & Karimi, M. (2026) · European Journal of Cancer · doi:10.1016/j.ejca.2026.116767
Oba, T., Hozaka, Y., Yoshida, T., Sinan, H., Sleiman, E. A., Shin, E. J., Afghani, E., Canto, M. I., & Goggins, M. (2026) · Gastro Hep Advances · doi:10.1016/j.gastha.2026.101027
Self-citationZhang, G., Shi, X. H., Wang, H., Yin, X., Guo, S., & Jin, G. (2026) · Research Square · doi:10.21203/rs.3.rs-9647757/v1
Early detection of pancreatic cancer by evaluating combined serum biomarker: The key questions
Noor, F., Rehman, M. S. U., Ambreen, U. E., & Sattar, T. (2026) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v18.i7.115270
Okumura, K., Kozaka, K., & Kobayashi, S. (2026) · Digestive Diseases and Sciences · doi:10.1007/s10620-026-10065-x
Hereditary Pancreatic Cancer: Genetic Risk, Surveillance Strategies, and Therapeutic Implications
Marafioti, M., Patruno, M., Musarra, M., Silvestris, N., Funes, J. A. P., Omero, F., Sapuppo, E., Cianci, V., Calabrò, M., Irrera, N., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146404
Li, D., Zhang, N., Li, R., Tian, Y., Gao, L., & Zhang, G. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1868121
Precision Pancreatic Cancer Care: From Early Detection to Adaptive Precision Oncology
Okabayashi, T., Tabuchi, M., Tokumaru, T., Uemura, S., & Tamura, S. (2026) · Cancer Investigation · doi:10.1080/07357907.2026.2721529
Levinson, E. J., Hilfrank, K., Rustgi, S., & Kastrinos, F. (2026) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2026.07.002
Age-specific pancreatic cancer risk in Italian CDKN2A families
Dalmasso, B., Allavena, E., Gambino, A., Barbero, F., Vanni, I., Görgün, C., Cittadini, G., Spagnolo, F., Tanda, E. T., Boutros, A., et al. (2026) · Digestive and Liver Disease · doi:10.1016/j.dld.2026.09.004
IPMN beyond the cyst: toward a broader framework of pancreatic and systemic cancer susceptibility
Okabayashi, T., Tabuchi, M., Tokumaru, T., Uemura, S., & Tamura, S. (2026) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2026.2737415
Masuda, A., Tsujimae, M., Ko, T., Miki, M., Okamoto, K., Ogawa, K., Kageyama, T., Tokunaga, T., Kawase, Y., Kanamaru, K., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-11014749/v1
Sinan, H., Sleiman, E. A., Blackford, A. L., Shinozuka, T., Melki, D., Saab, J., Romanos, M., Ning, K., Almardini, M., Castellino, A., et al. (2026) · Pancreatology · doi:10.1016/j.pan.2026.10.013
Self-citation
Metadata
- Authors
- Canto, M. I., Harinck, F., Hruban, R. H., Offerhaus, G. J., Poley, J.-W., Kamel, I., Nio, Y., Schulick, R. S., Bassi, C., Kluijt, I., Levy, M. J., Chak, A., Fockens, P., Goggins, M., & Bruno, M.
- Affiliations
- Johns Hopkins University (US)
- Erasmus MC (NL)
- Utrecht University (NL)
- Department of Radiology, Academic Medical Center, Amsterdam, The Netherlands
- Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
- University of Verona (IT)
- Amsterdam UMC Location University of Amsterdam (NL)
- Mayo Clinic (US)
- University Hospitals of Cleveland (US)
- Corresponding author
- Canto, Marcia Irene
- ORCID
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2012-11-07
- Volume
- 62
- Issue
- 3
- Pages
- 339-347
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- PMC
- PMC3585492
- OpenAlex
- W2111705409
- Cited by
- 784
- References
- 88
- Citations by year
- 2026: 23 · 2025: 23 · 2024: 40 · 2023: 53 · 2022: 66 · 2021: 73 · 2020: 61 · 2019: 82 · 2018: 82 · 2017: 67 · 2016: 71 · 2015: 69 · 2014: 45 · 2013: 23 · 2012: 6
- FWCI
- 22.79
- Type
- journal article
- Language
- en
- Update notices
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Gut (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, other-oa)
- Utrecht University Repository (Utrecht University) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- Leiden Repository (Leiden University) (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- National Cancer Institute (K24CA113433, P30CA006973)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- pancreatic cancer screening, familial pancreatic cancer, genetic susceptibility, pancreatic intraepithelial neoplasia, intraductal papillary mucinous neoplasm, Peutz-Jeghers syndrome, BRCA2 mutation carriers, Lynch syndrome, endoscopic ultrasound, surveillance interval, surgical management, high-volume centers, multidisciplinary team, consensus recommendations
- MeSH terms
- Age Factors, Carcinoma, Follow-Up Studies, Humans, Mutation, Pancreatectomy, Pancreatic Neoplasms, Pedigree, Risk Factors, Treatment Outcome, Endosonography, Genetic Predisposition to Disease, Cholangiopancreatography, Magnetic Resonance, Early Detection of Cancer, Neoplasm Grading
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
